103 results on '"Lipiecki J."'
Search Results
2. 2 years outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The Biofreedom France Study
3. Biofreedom France registry: A prospective evaluation of clinical outcomes in real-world patients treated by coronary angioplasty with Biolimus A9 polymer-free Biofreedom stents
4. Assessment of left ventricular volumes and function by cine-MR imaging depending on the investigator’s experience
5. The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation
6. Results of the multicenter, prospective, randomised STRENGTH (Study To evaluate the use of RENalGuard to proTect patients at High risk of acute kidney injury) study
7. Prévalence des sténoses des artères rénales dépistées au cours de coronarographies diagnostiques : dans quels cas doit-on réaliser une aortographie abdominale ?: À propos de 467 patients
8. The leaders free trial: A double blind randomized comparison of a BMS and a polymer-free Drug Coated Stent (DCS) in 2,466 patients at high bleeding risk and treated with one month DAPT only.
9. Bivalirudin use in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Insights from the prospective, multi-centre EUROVISION registry
10. Silent cerebral infarcts after cardiac catheterization: a randomized comparison of radial and femoral approaches
11. Assessment of left ventricular volumes and function by cine-MR imaging depending on the investigator’s experience
12. 1.12Evaluation of infarct size in patients with acute myocardial infarction treated by primary coronary intervention after intracoronary or intravenously bolus administration of Abciximab
13. 1.48Comparison of infarct size and severity in patients reperfused <12 hours and >12 hours after the onset of chest pain
14. Fonction ventriculaire gauche en IRM : comparaison avec l’angiographie invasive chez 30 patients
15. Influence of infarct-zone viability detected by rest Tc-99m sestamibi gated SPECT on left ventricular remodeling after acute myocardial infarction treated by percutaneous transluminal coronary angioplasty in the acute phase
16. A patent heart failure is the most predictive factor of in‐hospital mortality in patients > 80 years old hospitalised with the diagnosis of ischemic heart disease
17. Does PTCA Improve Regional Wall Motion Abnormalities in the Late Phase of a First Myocardial Infarction?
18. Pleuropéricardite révélant un myélome multiple
19. Comparison between Tl-201 and Tc-99m-tetrofosmin normal data base in SPECT sectorial quantification
20. Detection of residual viability with Tc-99m-sestamibi or Tl-201 in the late phase (>4 Wks) of myocardial infarction
21. Coronary stents and chronic anticoagulation.
22. Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results.
23. 1.48: Comparison of infarct size and severity in patients reperfused 12 hours after the onset of chest pain
24. 1.12: Evaluation of infarct size in patients with acute myocardial infarction treated by primary coronary intervention after intracoronary or intravenously bolus administration of Abciximab
25. Tl-201 SPECT better predicts prognosis than dobutamine echocardiography
26. 1.48: Comparison of infarct size and severity in patients reperfused <12 hours and >12 hours after the onset of chest pain
27. Comparison between rest thallium 201 and technetium 99m-labeled tetrofosmin imanging for assessment of defect severity after myocardial infarction
28. Redistribution of Tc-99m-tetrofosmin for the detection of residual myocardial viability
29. Comparison between Tl-201 and Tc-99m-tetrofosmin: Quantitative analysis in chronic coronary artery disease
30. The role of intra-vascular imaging in patients undergoing intravascular lithotripsy: Insights from the COIL registry.
31. Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 years.
32. Clinical outcomes of coronary intravascular lithotripsy in patients with stent failure (COIL registry).
33. Percutaneous mitral annuloplasty with the Carillon device: Outcomes in proportionate and disproportionate functional mitral regurgitation.
34. Rotational Atherectomy Versus Intravascular Lithotripsy for Calcified In-Stent Restenosis: A Single-Center Study With 1-Year Follow-Up.
35. Editorial commentary: Functional mitral regurgitation - a moving target in patients with heart failure.
36. Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study.
37. Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative.
38. Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI.
39. Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT Registry.
40. Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
41. Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitation.
42. Transcatheter treatment of functional mitral valve regurgitation.
43. Transcatheter Mitral Valve Repair: When Is the Last Moment Before Crossing the Styx River?
44. Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trial.
45. Long-term prognosis of patients treated by coronary sinus-based percutaneous annuloplasty: single centre experience.
46. Long-Term Survival Following Transcatheter Mitral Valve Repair: Pooled Analysis of Prospective Trials with the Carillon Device.
47. The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation.
48. Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial.
49. Safety and efficacy outcomes of 3rd generation DES in an all-comer population of patients undergoing PCI: 12-month and 24-month results of the e-Biomatrix French registry.
50. A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.